Podcasts about Migraine

That “healthy” dessert trending all over TikTok? It might look nourishing. It might even be labeled “anti-inflammatory.”But for a migraine-prone brain, it could be quietly slowing your recovery.In this episode of The Migraine Heroes Podcast, host Diane Ducarme explores how viral wellness trends can bypass one critical question: How does this affect a sensitive nervous system? Because what fuels muscle growth or gut health on social media doesn't always support a brain healing from migraine.You'll discover:

Dr. Tesha Monteith talks with Dr. Jennifer Robblee about the latest consensus on refractory migraine, its definition, and management strategies, including new guidelines for emergency treatment.  Read the related article in Cephalalgia.  Read the related article in Headache. Disclosures can be found at Neurology.org. 

Some migraines don't start with food, screens, or hormones. They start with people.In this episode of Migraine Heroes Podcast, host Diane Ducarme explores a trigger that's rarely named but deeply felt: repeated boundary violations. The subtle stress of being interrupted, dismissed, pressured, or emotionally overstepped can quietly keep your nervous system on high alert… until your head pays the price.This episode unpacks why “it's not that bad” interactions can still be biologically loud for a migraine brain and what you can do to protect yourself without guilt or confrontation.In this episode, you'll learn:

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Amaal Starling, MD, FAHS, FAAN, joins the podcast to provide clinical perspective on the INFUSE real world study evaluating IV eptinezumab in adults with migraine who previously found one or more CGRP preventive options ineffective, based on data presented at the 2026 Headache Cooperative of the Pacific Annual Conference. Starling, an associate professor of neurology at Mayo Clinic College of Medicine and a study author on INFUSE, discusses how clinicians should interpret the magnitude of benefit in a high burden population and why IV delivery, including rapid and consistent bioavailability, may help explain early and sustained response. The conversation also explores what the findings suggest for real world care and treatment sequencing, how migraine trials can better capture patient experience through outcomes like good days and PGIC, and what precision medicine research could look like next as the field pushes toward predictive modeling and individualized treatment selection.Looking for more Headache & Migraine discussion? Check out the NeurologyLive® Headache & Migraine clinical focus page.Episode Breakdown: 1:20 – Interpreting real world response after prior CGRP preventive failure 4:25 – Mechanistic reasons IV eptinezumab may drive early sustained benefit 6:25 – Clinical implications for earlier, more robust treatment sequencing 8:50 – Neurology News Network  11:20 – Integrating good days and Patient Global Impression scales into migraine trial design 15:30 – Future studies needed to advance precision migraine care The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: Fenebrutinib Achieves Primary End Point in Phase 3 Head-to-Head Trial vs Teriflunomide in Relapsing MS Praxis Submits NDAs for Ulixacaltamide in Essential Tremor and Relutrigine in SCN2A/SCN8A Developmental Epileptic Encephalopathies Efgartigimod Meets Primary End Point in Phase 3 ADAPT OCULUS Study of Ocular Myasthenia Gravis Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

La Dre Marzieh Eghtesadi, médecin au CHUM et chercheuse au CRCHUM, remporte le Prix de l'innovation du Département de médecine de famille et de médecine d’urgence de la Faculté de médecine de l'Université de Montréal pour sa contribution aux soins des patients souffrant de migraines à travers ses activités d’enseignement innovatrices Entrevue avec Dre Marzieh Eghtesadi, médecin au Centre hospitalier de l'université de Montréal (CHUM). Regardez aussi cette discussion en vidéo via https://www.qub.ca/videos ou en vous abonnant à QUB télé : https://www.tvaplus.ca/qub ou sur la chaîne YouTube QUB https://www.youtube.com/@qub_radioPour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Daylight Saving Time can disrupt your sleep—and that disruption can directly affect headaches and migraines.In this episode of The Headache Doctor Podcast, Dr. Jono Taves explains why sleep quality is one of the most important foundations for reducing headache and migraine frequency. As the clocks change and we lose an hour of sleep, many people experience increased fatigue, higher stress levels, and a lower tolerance for pain.Dr. Taves breaks down how sleep influences your pain threshold, inflammation, neurotransmitters, and nervous system regulation, and why poor sleep can make headache triggers hit harder.You'll also learn practical strategies to improve sleep quality, including optimal sleep positions, breathing techniques, and simple habits that support a healthier circadian rhythm.If headaches or migraines tend to worsen around daylight saving time, this episode will help you understand why—and what you can do to protect your sleep and raise your body's resilience to pain.In this episode you'll learn:Why sleep is critical for headache and migraine recoveryHow poor sleep lowers your pain tolerance and increases inflammationWhy daylight saving time can trigger more headaches and migrainesThe best sleep positions to reduce neck tension and painHow nasal breathing and sleep routines improve sleep qualitySimple ways to protect your circadian rhythm and nervous systemNovera: Headache Center

You've probably heard about migraine prevention, but what does it actually mean? In Part 1 of this two-part Spotlight on Migraine series, host Molly O'Brien sits down with neurologist and headache specialist Dr. Jessica Ailani to break down the basics of migraine prevention. They discuss types of prevention, who should consider preventive treatment, why reducing migraine frequency matters, and how to set realistic goals focused on improving quality of life—not just lowering headache days. Read the transcript at https://www.migrainedisorders.org/pod... Dr. Ailani explains:  When migraine prevention is recommended (often around 5–6 migraine days per month) How to reshape our thoughts around prevention. It's not all about fewer headache days; it's about reducing disability, improving independence, and bettering quality of life. The full range of prevention options What to consider if you're hesitant to start due to side effects, cost, or insurance barriers This is the first part of the Association of Migraine Disorders' two-part series on migraine prevention. In Part 2, we'll dive into specific treatment options and how to tailor a prevention plan to work best for you. *The contents of this video are intended for general informational purposes only and do not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD does not recommend or endorse any treatment, products, or procedures mentioned. Reliance on any information provided by this content is solely at your own risk.

What unsuspecting dangers lie within a garden compost bin? The Case Reports team are back to uncover a new pair of neurological mysteries. The first case this episode (1:24) comes from Edinburgh, centred on an 88-yo woman who presents with headache and eye-pain on her right side. She receives an early diagnosis of migraine, but returns a few weeks later with intermittent vomiting and subsequent progressive visual loss. https://pn.bmj.com/content/26/1/83  The second case (19:51) from Wessex features a common presentation of tingling feet, with a 62-yo man who develops gait instability. More curious are a significant drop in his weight, as well as a scaly patch on his chest. https://pn.bmj.com/content/26/1/63   The case reports discussion is hosted by Prof. Martin Turner¹, who is joined by Dr. Ruth Wood² and Dr. Babak Soleimani³ for a group examination of the features of each presentation, followed by a step-by-step walkthrough of how the diagnosis was made. These case reports and many others can be found in the October 2025 issue of the journal. (1) Professor of Clinical Neurology and Neuroscience at the Nuffield Department of Clinical Neurosciences, University of Oxford, and Consultant Neurologist at John Radcliffe Hospital. (2) Clinical Lecturer in Neurology at the Institute of Cognitive Neuroscience, University College London, and an Honorary Neurology SpR at the National Hospital for Neurology and Neurosurgery. (3) Clinical Research Fellow, Oxford Laboratory for Neuroimmunology and Immunopsychiatry, Nuffield Department of Medicine, University of Oxford Please subscribe to the Practical Neurology podcast on your favourite platform to get the latest podcast every month. If you enjoy our podcast, you can leave us a review or a comment on Apple Podcasts (https://apple.co/3vVPClm) or Spotify (https://bit.ly/4aXF46i). We'd love to hear your feedback on social media - @PracticalNeurol. Production and editing by Brian O'Toole. Thank you for listening.

This episode revisits Dr. Sui Wong's insights on how the eyes are neural tissue that can reveal early signs of brain, vascular, and metabolic issues, and reframes migraine as a common, often invisible neurological condition that causes brain fog and cognitive symptoms. Actionable takeaways include scheduling regular dilated eye exams, stabilizing blood sugar, prioritizing sleep and retinal blood flow, reducing digital strain, and tracking migraine triggers to prevent worsening symptoms. In today's review of EP 342 with Dr. Sui Wong from August 2024, we cover:  • Why the eyes are considered an extension of the brain — and how the retina is neural tissue • How eye exams may provide early insight into overall neurological and vascular health • What drusen are, why small amounts can be age-related, and why monitoring retinal changes matters • The powerful idea that prevention begins before symptoms become severe • Why migraine is not “just a headache,” but a neurological condition affecting 1 in 7 people globally • The hidden symptoms of migraine — including brain fog, mood changes, word-finding difficulty, and cognitive slowing • Why migraine is a leading cause of disability in young women and often goes unrecognized • The connection between blood sugar regulation, sleep, stress, and neurological function • Practical ways to support long-term brain health through awareness, monitoring, and daily lifestyle habits • How small, consistent actions build cognitive resilience over time Welcome back to Season 15 of the Neuroscience Meets Social and Emotional Learning Podcast. I'm Andrea Samadi, and here we bridge the science behind social and emotional learning, emotional intelligence, and practical neuroscience—so we can create measurable improvements in well-being, achievement, productivity, and results. When we launched this podcast seven years ago, it was driven by a question I had never been taught to ask— not in school, not in business, and not in life: If results matter—and they matter now more than ever—how exactly are we using our brain to make these results happen? Most of us were taught what to do. Very few of us were taught how to think under pressure, how to regulate emotion, how to sustain motivation, or even how to produce consistent results without burning out. That question led me into a deep exploration of the mind–brain–results connection—and how neuroscience applies to everyday decisions, conversations, and performance. That's why this podcast exists. Each week, we bring you leading experts to break down complex science and translate it into practical strategies you can apply immediately. When the brain, body, and emotions are aligned, performance stops feeling forced—and starts to feel sustainable. Season 14 showed us what alignment looks like in real life. We looked at goals and mental direction, rewiring the brain, future-ready learning and leadership, self-leadership, which ALL led us to inner alignment. And now, Season 15 is about understanding how that alignment is built—so we can build it ourselves, using predictable, science-backed principles. Because alignment doesn't happen all at once. It happens by using a sequence. And when we understand the order of that sequence — we can replicate it. By repeating this sequence over and over again, until magically (or predictably) we notice our results have changed. Season 15 we've organized as a review roadmap, where each episode explores one foundational brain system—and each phase builds on the one before it. Season 15 Roadmap: Phase 1 — Regulation & Safety Phase 2 — Neurochemistry & Motivation Phase 3 — Movement, Learning & Cognition Phase 4 — Perception, Emotion & Social Intelligence Phase 5 — Integration, Insight & Meaning PHASE 1: REGULATION & SAFETY Staples: Sleep + Stress Regulation Core Question: Is the nervous system safe enough to learn? Anchor Episodes Episode 384[i] — Baland Jalal How learning begins: curiosity, sleep, imagination, creativity Episode 385[ii] — Bruce Perry “What happened to you?” — trauma, rhythm, relational safety Episode 387 Sui Wong Autonomic balance, lifestyle medicine, brain resilience Episode 388 Rohan Dixit HRV, real-time self-regulation, nervous system literacy Phase 1 — Regulation & Safety We have reviewed Dr. Baland Jalal where we were reminded that before learning can happen, before curiosity can emerge, before motivation or growth is possible—the brain must feel safe. Then we looked at trauma and relational safety with Dr. Bruce Perry's Book, What Happened to You, and we move onto Dr. Sui Wong, with autonomic balance, lifestyle medicine and brain resilience.

In this episode of PEM Currents: The Pediatric Emergency Medicine Podcast, we take a structured, evidence-based approach to the acute treatment of migraine in children and adolescents. From confirming the diagnosis and screening for concerning features to optimizing outpatient therapy and executing a protocolized emergency department strategy, this episode walks through what works. We review the role of NSAIDs and triptans, clarify how IV fluids and ketorolac fit into care, and provide a stepwise framework for dopamine antagonists, valproate bridge therapy, DHE protocols, steroids, discharge planning, and admission decisions. Practical dosing, reassessment timing, and family-centered communication strategies are emphasized throughout. Learning Objectives Recognize the clinical features of pediatric migraine and distinguish it from secondary causes of headache. Implement a stepwise, evidence-based emergency department approach to acute pediatric migraine, including appropriate medication selection and timing of reassessment. Develop safe discharge and follow-up plans by defining treatment endpoints, minimizing medication overuse, and identifying patients who require referral or inpatient management. References 1. Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice Guideline Update Summary: Acute Treatment of Migraine in Children and Adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2019;93(11):487-499. doi:10.1212/WNL.0000000000008095. 2. Patterson-Gentile C, Szperka CL. The Changing Landscape of Pediatric Migraine Therapy: A Review. JAMA Neurology. 2018;75(7):881-887. doi:10.1001/jamaneurol.2018.0046. 3. Bachur RG, Monuteaux MC, Neuman MI. A Comparison of Acute Treatment Regimens for Migraine in the Emergency Department. Pediatrics. 2015;135(2):232-238. doi:10.1542/peds.2014-2432. 4. Ashina M. Migraine. The New England Journal of Medicine. 2020;383(19):1866-1876. doi:10.1056/NEJMra1915327. 5. Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the Acute Treatment of Migraine in Children and Adolescents. The Cochrane Database of Systematic Reviews. 2016;4:CD005220. doi:10.1002/14651858.CD005220.pub2. Transcript This transcript was generated using Descript automated transcription software and has been reviewed and edited for accuracy by the episode's author. Edits were limited to correcting names, titles, medical terminology, and transcription errors. The content reflects the original spoken audio and was not substantively altered. And today we're gonna talk about the acute treatment of migraine headache in children and adolescents. This is bread and butter for the PED, requires precise diagnosis and evidence-based treatment. We're gonna talk about making that diagnosis, red flags, outpatient and ED treatment, as well as some second-line agents, admission decisions, and a whole lot more. So migraine in children is defined by three criteria, and at least five attacks lasting two to 72 hours. So you gotta have at least two of the following: pulsating or throbbing quality, moderate to severe intensity, aggravation by routine activity, and a unilateral location. Although in children, it's often bilateral, plus at least one of nausea or vomiting and photophobia and/or phonophobia. In children headaches are frequently bilateral, bifrontal, bitemporal. The duration might be shorter than adults, especially in kids under second or third grade. And you may have to infer whether or not they have photophobia from their behavior. Like does the child close their eyes or wanna go into a dark room? In the emergency department, we're often diagnosing based on pattern recognition plus exclusion of dangerous secondary causes. Or even more often than that, the patient comes in and says, I've got a migraine. Before I move on to treatments, let's talk about some red flags where you might wanna pause and not just jump to migraine therapy. And the mnemonic SNOOP can be helpful here. And it stands for S for systemic symptoms such as fevers, myalgia, weight loss, or another S, secondary risk factors such as an immune deficiency, cancer, pregnancy, N for neurologic signs, papilledema, focal deficit, confusion, seizures. O onset sudden, or thunderclap. Migraines are often a little more gradual than that. The other O is older age, or technically younger age too, younger than five years or older than 50. Hopefully those patients are not coming into the pediatric emergency department. And then pattern changes, these new symptoms in a previously stable pattern. Don't ignore that. And precipitants, you know, is it worse with Valsalva, position change, or under significant exertion? If these signs are present, you'll probably wanna take a pause and just not throw migraine treatment at the patient. If they're stable, MRI is the preferred imaging modality, but a very sick patient, it'd be okay to get a head CT. If you've got a normal neurologic exam, there's no red flags. Again, you don't need routine imaging for migraine headaches. So let's talk about treatment. So hopefully patients have actually started to treat their headache before they arrive in the emergency department. If they haven't, it's a good idea to have some triage protocols in place. So ibuprofen, 7.5 to 10 milligrams per kilogram, 10 milligrams per kilogram is superior to placebo and it's superior to acetaminophen at two hours. So that's what we would use. Early treatment's critical. So ideally within the first hour of onset. So that's why triage protocols help. We'll give kids 10 mg per kg of ibuprofen and like 30 ounces of Gatorade. Blue is often the first Gatorade choice, though that's not an evidence-based statement. You can also use naproxen, but most of the studies are on ibuprofen. If NSAIDs fail, many adolescents and some older children will be prescribed triptans. The best evidence currently supports sumatriptan plus naproxen or zolmitriptan nasal spray. Rizatriptan is FDA approved down to age six. Adolescents respond to these agents better than younger children, and the route matters. The nasal formulations help when nausea is prominent. Families should be counseled to treat early, use weight-appropriate dosing, and avoid using acute medications more than 10 days per month. Often patients will have already taken an NSAID and a triptan before they get to the ED, and that's where we get into the treatment of refractory migraine. Now this is most of the patients that I will see, and before we push medications, let's briefly review ED treatment goals. You either want the patient headache free. Back to their baseline or mild descending pain. So a pain score of one to three. If you don't reach one of those endpoints and it's not agreed upon with the patient and their family, you've not completed treatments. You should do a reassessment within one hour after each intervention. And let's face it, if you're not reassessing within an hour and defining treatment goals, you're not practicing protocolized migraine care. So in the emergency department, many of you may be familiar with the migraine cocktail. So what is that? In general, it's a dopaminergic agent such as prochlorperazine or metoclopramide plus ketorolac, plus IV fluids. Let's take a look at all three of those components and see if you can guess which one is actually the one that can abort the migraine. So fluids are commonly given in pediatric migraine, but they alone do not treat it. They're helpful. Many patients have been throwing up or a bit dehydrated, but there are small randomized trials that show essentially no meaningful pain reduction in patients that get IV fluids alone. Well, what about ketorolac? Toradol, like that's the first thing you give to a kid with a kidney stone, right? It does help, but it's really adjunctive. So the main first-line agents for refractory or status migrainosus in the emergency department are the dopamine antagonists, and the first-line treatment for most patients is prochlorperazine or Compazine. The dose is 0.15 milligram per kilogram IV. The max is 10 milligrams. This is the backbone of ED migraine care. And why do they work? Well, migraines aren't just some random vascular headache. This is an inherited disorder with central pain pathways gone awry. Dopamine plays a large role in that pain, nausea, hypersensitivity, amplification of symptoms and more that, frankly, I won't get into this podcast because molecules hurt my head. The dopamine antagonists treat the headache, they reduce the nausea, and they just tamp down this process. Overall, the response rates approach 85%. Some studies have suggested that the response rate is about 77% at an hour and 90% at three hours. If you add the ketorolac and IV fluids, you get your response rate up to about 93 to 94%. These agents really do work well together. There have been randomized trials comparing IV prochlorperazine versus ketorolac. 85% of prochlorperazine patients achieved headache relief versus only 55% of ketorolac patients. So ketorolac helps, but really it's the prochlorperazine. Metoclopramide, or Reglan, is used in a lot of centers as well. There are some smaller studies in children and adolescents that show that prochlorperazine is more effective, but if kids have an adverse reaction, more on that in a moment, or they prefer metoclopramide because they've responded to it in the past, it's okay to go with it as well. Right. So what does it actually look like when you give the migraine cocktail to a patient? I think it's important to explain to patients and families what to expect, and if this is a teenager, I'm talking to them directly. I mean, they're getting the medication first and foremost. I tell them that the most effective way to treat their headache is with an IV. This often causes lots of angst, even in older teenagers. The medication just does not get to the brain as effectively and fast enough if you take it by mouth. Many patients who get the dopaminergic agents, so prochlorperazine, will invariably feel jittery or anxious or like they gotta move or like they got ants in their pants. I tell them to expect this so they're not surprised and worried when it happens. I tell them that once they start feeling that way, it means the medicine is probably working. They need to hit the nurse button and we're gonna get them up and have them take a walk. This fixes it for the majority of patients just getting up and moving. In adult centers, even with the initial administration of the prochlorperazine or as sort of a reflexive response to any of those symptoms, they just give a slug of IV Benadryl. There's some studies in adolescents especially that this may decrease the effectiveness of the IV agents you're giving in the first place, and it may also increase return rates to the ED. So I will use IV diphenhydramine if getting up and moving around isn't working, or if the distress is significant, or if the patient clearly indicates they've needed it in the past. So if after the migraine cocktail, the patient has met their pain goals and the reassessment is favorable, they can go home to outpatient follow-up. How about if the headache got better, but not all the way? It's usually when the initial migraine cocktail didn't achieve the pain endpoints fully, like it helped partially. If the dopamine blockade didn't do anything, valproate is unlikely to rescue the case. And so valproate works on GABA and it stabilizes some of these pain processes, but the dopaminergic agent needs to have done something first for valproate to work. Per the most common protocol, you give an initial dose of IV valproate, then you discharge the patient home on Depakote ER. So oral valproic acid under 10 years old or under 50 kilograms, 250 milligrams PO twice a day for two weeks, or older than 10 or greater than 50 kilos, 500 milligrams twice a day for two weeks. This is the extended release and it's most helpful if you give the first oral dose in the emergency department. So that's why it's very important to build this protocol in advance. If you don't have IV valproate, then don't just give the patient oral valproate, and definitely don't prescribe an oral course for discharge. All right, well, what about DHE? Dihydroergotamine for refractory or status migrainosus? Generally, this is only given at pediatric centers where you have neurology coverage. It's contraindicated if you've had another dose of DHE within 14 days, or you've had any triptan of any sort within 24 hours, and you must obtain a pregnancy test in adolescent females before giving it. The dosing for less than 30 kilograms is 0.5 milligram. At least 30 kilograms is one milligram. You give 50% of the dose over three minutes, then the remaining 50% over 30 minutes. If this is gonna work, the patients are gonna start feeling wretched at first. They're gonna get very nauseous and they're gonna vomit. They're gonna have flushing, and you'll see transient hypertension. Most of that resolves within the hour in most centers. If you're committing to DHE, you're kind of bringing the patient into the hospital anyway, though some facilities will have DHE done in the emergency department with close outpatient follow-up. Either way, it's really best practice to involve child neurology if you're giving DHE. Alright, well what about steroids? They give those in grownups too, right? Steroids really only have a role for recurrence prevention in children. So for kids that have a history of returning within 72 hours for rebound headache, you can give dexamethasone 0.6 milligram per kilogram IV dose, the max of 10 milligrams. You do not discharge them home on a steroid prescription or a Medrol dose pack or something else, and this can cut the recurrence risk down a bit. There's other therapies out there like magnesium and ketamine. There's just not enough evidence there. And the purpose of this episode is to discuss the therapies that have good evidence behind them and should be part of protocols across the country. Some patients are unfortunately not responsive to emergency department therapy and need admission. The main inpatient therapy is the DHE protocol. If they're not DHE eligible, they haven't tolerated it well or it's unavailable, admission's unlikely to help them unless they just need some IV fluids to help them get back up on their feet. You should consult neurology if the headache goals are not met after maximizing ED therapy for advice. And we should definitely avoid opioids. They don't treat patients with migraines. They increase recurrence risk. They increase revisit rates. Again, the dopamine antagonist prochlorperazine, it's superior for sustained relief when families ask about them, and fortunately they're asking about opioids far less. We use medications that treat the migraine pain pathways and signaling. We don't just wanna mask the pain. All right, so that's all I've got on the acute management of migraine headaches, especially in the emergency department. Remember that migraine care in the ED should be protocolized and evidence-based. IV fluids are supportive. Prochlorperazine is the first line, or you can use metoclopramide as well. Ketorolac is an adjunctive therapy. Valproate is next line. If you've gotta escalate, and DHE is specialized therapy, you can start in the ED, but most of these patients are getting admitted. Dexamethasone or steroids in children can reduce recurrence risk, but they're not really part of the acute management. You should definitely define the endpoints and structurally and systematically reassess patients at an hour. The goal is to get them feeling better to a defined endpoint and to restore function. There is evidence-based pediatric emergency migraine care. You should understand that, plus how to explain why these agents are being given and some of the side effects to patients and families. I find that that approach increases your likelihood of buy-in and success. Alright, so that's it for this episode on the Acute Management of Migraine Headaches in Children and Adolescents. I hope you found it helpful and I can pretty much guarantee that you're gonna see a patient with a migraine on your next shift. If you've got any feedback or comments, send them my way. If you like this episode, leave a review on your favorite podcast site. It helps more people find the show. Or recommend it to a colleague. If there's other topics that you'd like to hear, send them my way for the Pediatric Emergency Medicine podcast. This has been Brad Sobolewski. See you next time.    

Success looks good in the daylight, but at night, it often looks very different. In this episode we explore why insomnia is so common in driven, high-achieving, Type-A personalities. Is it stress? Hyperarousal? The Zeigarnik effect? We unpack the science, the psychology, and the cultural narrative that may be quietly rewarding sleeplessness. In this episode, we will:Discover what the research says about achievement orientation, perfectionism, and insomniaOutlinehyperarousal model of insomnia and why high performers may struggle to “turn it off”Introduce the Zeigarnik effect and how unfinished goals hijack the sleeping brainLearn why our culture romanticizes sleepless productivity and how that reinforces the problemContrast the difference between short sleepers, workaholism, and true chronic insomniaThink about practical strategies for high achievers to protect sleep without sacrificing ambitionOriginal intro music Vigilanteology by Abhinav Singh (copyright 2026) Original outro music Vigilanteology (reprise) by Abhinav Singh (copyright 2026)Produced by: Maeve Winter Music by: Dr. Abhinav Singh (@sleep_vigilante), all rights reserved More Twitter: @drchriswinter IG: @drchriwinter Threads: @drchriswinter Bluesky: @drchriswinter The Sleep Solution and The Rested Child Thanks for listening and sleep well!

In this episode of The Headache Doctor Podcast, Dr. Jono Taves explains why having a clear migraine treatment plan is one of the most important factors in long-term healing.Too often, headache and migraine sufferers are given medication without a clear explanation of why their symptoms are happening or how to move forward. Dr. Taves shares a personal story from his newborn son's recent hospital stay to illustrate how powerful it is when a provider explains the “why” and lays out a clear direction.You'll learn:Why uncertainty makes migraines feel worseThe difference between symptom suppression and root-cause careWhy time can work for you instead of against youHow the Three-Spoke framework identifies the source of pain, barriers to healing, and systemic health contributorsWhy medication alone often fails to solve chronic headachesIf you've ever felt stuck, confused, or dismissed in your migraine care, this episode will help you understand why having a plan changes everything.Novera: Headache Center

That constant low-level worry, “Will this trigger a migraine?”, might feel protective. But what if it's quietly doing the opposite?In this episode of Migraine Heroes Podcast, host Diane Ducarme explores how migraine-related anxiety subtly reshapes the brain and nervous system, often increasing the likelihood of your next attack without you realizing it.This isn't about fear, weakness, or “overthinking.” It's about biology. When anxiety becomes intertwined with migraine, it can lock your system into anticipation mode, keeping pain pathways primed and hyper-reactive.In this episode, you'll discover:

Listen to Dr. Tom Roselle, DC and learn reasons why Botox is dangerous as treatment for migraines, from common and mild side effects to critical safety warnings and life-threatening complications, including dysphagia, muscle weakness near the injection site, neck pain or stiffness, worsening of migraine symptoms, and more. For more episodes of Ageless Health® with Dr. Tom Roselle, DC please visit: https://www.drtomroselle.com/ageless-health-podcast/ #AgelessHealth @DrTomRoselleDC @WMALDC @RoselleCare #AppliedKinesiology #RoselleCenterForHealing #HolisticHealth #IntegrativeHealth #FunctionalMedicine #HealthEducation #chronicheadaches #migraines #botox

In this episode, we review advancements in migraine care and the standardization that can help physicians and other practitioners take the pain out of managing this condition, treating and preventing symptoms. https://drive.google.com/file/d/1YqEz5Ih_lmOnAk7nJsddfu8uXb3dYVjr/view?usp=sharing Supported by Pfizer

In this episode, we discuss two innovative migraine treatments recommended by NICE. We explore the rapid uptake across the NHS with our three guests. We're joined by Joanne McShane, an NHS health visitor who suffered from migraine for a decade; Dr Kay Kennis, GP with an extended role in Headache at Bradford Community Neurology Service; and Rob Music, chief executive at The Migraine Trust.

Drs. Ailani and Dougherty discuss onabotulinumtoxinA, a cornerstone treatment for chronic migraine, which reduces headache days and disability when given regularly with the PREEMPT protocol. They emphasize its unique benefits and how it pairs with CGRP therapies, oral preventives, and lifestyle changes for individualized care.

Neurology is amazing in a crisis. Stroke at 3 a.m.? Seizure in the ER? Modern medicine delivers. But chronic brain issues are different. Migraine. Brain fog. Parkinson's. Alzheimer's risk. These often turn into symptom management with a fancy label and a longer medication list. In this episode of Medical Disruptors, I sit down with neurologist Dr. Ken Sharlin to talk about what comes before the diagnosis gets permanent. Why decline isn't inevitable. And why the real leverage points aren't “more meds” or “more supplements”—it's the inputs that shape inflammation, metabolism, and nervous system stability. Dr. Sharlin breaks down his 5-part clinical roadmap for brain health, explains why getting the diagnosis right actually matters, and walks through the early drivers that can show up years before symptoms become irreversible. We also go deep on migraines—what they really are, why your brain can get stuck on high alert, and how you bring the system back under control. If you want brain health guidance that's grounded, practical, and not fear-based, hit play. Want more practical health tips? Join my newsletter! https://freechapter.lpages.co/newsletter-opt-in/ Check us out on social media: drefratlamandre.com/instagram drefratlamandre.com/facebook drefratlamandre.com/tiktok #functionalmedicine #drefratlamandre #medicaldisruptor #NPwithaPHD #nursepractitioner #medicalgaslighting Chapters: [00:00:00] Sharlin's path [00:06:10] Acute vs chronic [00:10:20] Five pillars roadmap [00:22:40] Alzheimer's early drivers [00:34:20] Migraine threat circuitry Guest Links: FB: https://www.facebook.com/SharlinHealthandNeurology IG: https://www.instagram.com/sharlinhealthandneurology/ YT: https://www.youtube.com/@dr.kensharlin1548 Website:https://functionalmedicine.doctor Learn more about your ad choices. Visit megaphone.fm/adchoices

Can your vision be driving your headaches, dizziness, or brain fog—even if you have 20/20 eyesight?In this episode of The Headache Doctor Podcast, Dr. Taves sits down with neuro-optometrist Dr. Michael Saxerud to explore how the brain processes vision and why visual dysfunction is often an overlooked root cause of headaches and migraines.They break down the difference between eyesight and brain-based vision, and how misalignment between the eyes, vestibular system, and neck can create symptoms like:Headaches and migrainesLight sensitivityDizziness and nauseaBrain fogPoor balance or clumsinessReading fatigue and difficulty concentratingDr. Saxerud explains how tools like yoked prism lenses, peripheral occlusion (tape on glasses), and syntonic light therapy help recalibrate the brain's sense of “self in space,” reducing stress on the nervous system and improving functionIf you've been told your eyes are “fine” but you still struggle with headaches or visual discomfort, this episode will open your eyes to a powerful, non-medication approach to relief.Novera: Headache Center

Could your sugar cravings be quietly setting the stage for your next migraine, even if you think you “handle carbs just fine”?In this episode of Migraine Heroes Podcast, host Diane Ducarme explores one of the most misunderstood migraine triggers: blood sugar instability. Not sugar itself but the spikes, crashes, and nervous-system stress that come with it.Many people with migraines are told to “just cut sugar.” But migraine brains don't respond well to restriction or perfection. They respond to rhythm, stability, and context.This episode breaks down why blood sugar swings matter and how to work with cravings instead of fighting them.In this episode, you'll learn:

Step into a cool mountain sanctuary created to soothe migraines, calm inflammation, and ease headache discomfort. Gentle breathwork and cooling imagery help quiet overactive nerves and invite deep, healing sleep. Here, relief unfolds slowly, softly, and safely. It's time to dream away. Original Script, Narration, Sleep Music, and Sound Design by Michelle Hotaling, Dreamaway Visions LLC 2026 All Rights Reserved✨YOUTUBE: www.youtube.com/michellessanctuary

In this episode of Mining the Comments, Coach Daniel (sleep physician turned sleep coach and founder of the Sleep Coach School) responds to a powerful community question: “I have a terrible migraine, rendering me unable to sleep at all. Could you do an episode about how to sleep with pain?” In this video, we explore the deep connection between pain, fear, and sleep, and why trying to force sleep or eliminate pain often makes both worse. You'll learn how insomnia and chronic pain follow the same fear-based loop, and how relief begins—not by fighting symptoms—but by removing the sense of threat.

In this episode of Talk Dizzy To Me, vestibular physical therapists Dr. Abbie Ross, PT, NCS and Dr. Danielle Tolman, PT sit down with Kayla McCain, who shares her lived experience with Vestibular Migraine and PPPD (Persistent Postural-Perceptual Dizziness).Kayla opens up about what symptoms she experienced, the long road to getting correctly diagnosed, and the strategies that helped her get back to living life again and rebuilding her confidence. Key Takeaways:-Validation and education reduce fear-Vestibular migraine vs. PPPD presentations -Recovery is often multi-factorial-The “dizzy–anxious-dizzy cycle” is real-Small strategies matter in real life-Advocate for yourselfWhere to find Kayla:nInstagram: @true_kaylaismsHosted by:

In this final episode of the Progesterone Promise series, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, breaks down one of the most misunderstood hormones in women's health: progesterone. Progesterone is not “good” or “bad.” It's contextual. In today's world of quick sound bites and social media medicine, hormones are often reduced to oversimplified claims like “progesterone fixes anxiety” or “progesterone causes breast cancer.” The truth? It depends on your body, your stress levels, your liver health, your inflammation, your delivery method, and whether you're using bioidentical progesterone or synthetic progestins.   Citations: 1. Oral Progesterone → First-Pass Metabolism & Allopregnanolone Claim: Oral micronized progesterone undergoes significant hepatic first-pass metabolism, increasing neuroactive metabolites (especially allopregnanolone), which positively modulate GABA-A receptors and produce sedative/anxiolytic effects. Core Evidence: Simon et al., 1993; de Lignières et al., 1995; Freeman et al., 1990 — Oral progesterone produces measurable neuroactive metabolites. Paul & Purdy, 1992; Rupprecht et al., 2001 — Allopregnanolone enhances GABA-A receptor activity. Supports: Sedation variability by route • Neurosteroid generation • GABA-A modulation 2. Sulfation vs 5α-Reduction → Opposing Neurologic Effects Claim: Progesterone metabolites can produce calming (5α-reduced) or excitatory (sulfated) neurologic effects depending on enzyme routing. Core Evidence: Majewska et al., 1990 — Pregnenolone sulfate negatively modulates GABA-A. Wu et al., 1991 — Sulfated neurosteroids enhance NMDA signaling. Schumacher et al., 2007; Reddy, 2010 — Pathway reviews of sulfation vs 5α-reduction. Supports: Reverse responding hypothesis • Divergent neurologic experiences • Enzyme-dependent effects 3. Stress & Enzyme Modulation Claim: Chronic stress alters HPA axis tone and hepatic enzyme expression, influencing steroid metabolism balance. Core Evidence: McEwen, 1998 — Allostatic load model. Charmandari et al., 2005 — Cortisol's systemic regulatory effects. Zanger & Schwab, 2013; Gibson & Skett, 2001 — Stress alters cytochrome P450 expression. Supports: Stress-biased metabolism • Context-dependent hormone response 4. Breast Tissue Signaling & Context Claim: Progesterone influences mammary differentiation and interacts with estrogen signaling in context-dependent ways. Core Evidence: Brisken & O'Malley, 2010 — Progesterone receptor biology in breast tissue. Beleut et al., 2010 — RANKL mediates progesterone-driven proliferation. Hofseth et al., 1999 — PR-ER signaling interaction. Stanczyk & Bhavnani, 2014 — Natural vs synthetic differences in breast effects. Supports: Lobuloalveolar differentiation • RANKL pathway • Context-dependent proliferation 5. Synthetic Progestins vs Bioidentical Progesterone Claim: Synthetic progestins differ structurally and bind off-target receptors, producing distinct tissue effects. Core Evidence: Stanczyk et al., 2013 — Receptor binding differences. Sitruk-Ware, 2004 — Biologic comparisons. Chlebowski et al., 2003 (WHI) — Breast cancer signal with CEE + MPA. Supports: Structural divergence • Receptor-level differences • WHI clarification 6. Route of Delivery Differences Claim: Oral, vaginal, transdermal, and sublingual progesterone produce distinct pharmacokinetic profiles and tissue targeting. Core Evidence: Simon, 1995 — Oral vs vaginal PK comparison. Cicinelli et al., 2000 — “First uterine pass effect.” Wren et al., 2003 — Route-dependent systemic levels. Supports: Uterine targeting • Neurosteroid variability • Sedation differences 7. Progesterone, PMS & Migraine Claim: Neurosteroid fluctuations influence GABAergic tone and may contribute to PMS and migraine susceptibility. Core Evidence: Backstrom et al., 2011 — Allopregnanolone fluctuations in PMS. Reddy & Rogawski, 2002 — Neurosteroids and seizure threshold. Martin & Behbehani, 2001 — Hormonal fluctuations and migraine. Supports: Luteal neurosteroid shifts • GABA instability • Migraine association   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Headache pain can look like a minor annoyance until it starts stealing whole days. For many veterans, it is not a random ache that fades with water and a nap. It can be a complex, repeating neurological problem that shows up after exposures, stress, disrupted sleep, or injuries that never fully healed. This episode walks through why headaches and migraines hit the veteran community so hard, why the root cause often gets missed, and how to stop walking into appointments empty-handed. You will hear how the National Headache Foundation built Operation Brainstorm to make resources easier to find and use, including stories from veterans who live with this every day. The takeaway from this episode is treat this like a mission. Track attacks, document patterns, identify triggers, and bring a clean record to a dedicated appointment that stays focused on headache care. The conversation also covers the differences between preventive and abortive meds, how to advocate for referrals when primary care reaches its limits, and why specialized care, like the VA Headache Centers of Excellence, matters, especially for the hardest cases. This is for anyone tired of powering through and ready to build a plan that respects work, family, and the reality of living with pain. Timestamps: 01:47 - One third of veterans live with headaches and migraines 06:15 - Hundreds of headache types and why the label matters 09:45 - Cluster headache severity and the hidden days before head pain 13:45 - Build a plan, track patterns, walk in prepared 34:45 - VA Headache Centers of Excellence and the access fight Links & Resources Veteran Suicide & Crisis Line: Dial 988, then press 1 Websites: https://www.operationbrainstorm.org/ https://headaches.org/taking-charge/ Follow National Headache Foundation on Facebook: https://www.facebook.com/NationalHeadacheFoundation Follow National Headache Foundation on Instagram: https://www.instagram.com/nationalheadachefoundation/ Follow National Headache Foundation on Twitter: https://x.com/nhf Follow National Headache Foundation on LinkedIn: https://www.linkedin.com/company/national-headache-foundation/ Transcript View the transcript for this episode.

Driveway Beers PodcastHealth UpdateWhen we first started talking about our health, we said we would share the good and the bad of what happened. This episode is delivering on that promise. Mike has some good. Alex has some bad. We catch you up on all of it in this episode!! #health #weight #migraine #sinus #surgery #weightloss Please subscribe and rate this podcast on your podcast platforms like Apple and Spotify as it helps us a ton. Also like, comment, subscribe and share the video on Youtube. It really helps us get the show out to more people. We hope you enjoyed your time with us and we look forward to seeing you next time. Please visit us at https://drivewaybeerspodcast.com/donate/ to join The Driveway!!Leave us a comment and join the conversation on our discord at https://discord.gg/rN25SbjUSZ.Please visit our sponsors:Adam Chubbuck of Team Alpha Charlie Real Estate, 8221 Ritchie Hwy, Pasadena, MD 21122, www.tacmd.com, (443) 457-9524. If you want a real estate agent that will treat your money like it's his own and provide you the best service as a buyer or seller, contact Adam at Team Alpha Charlie.If you want to sponsor the show, contact us at contact@drivewaybeerspodcast.comCheck out all our links here https://linktr.ee/drivewaybeerspodcast.comIf you're looking for sports betting picks, go to conncretelocks.com or send a message to Jeremy Conn at Jconn22@gmail.comFacebook Page https://www.facebook.com/drivewaybeerspodcast/#podcast #whiskey #bourbon

In part two of this series, Dr. Tesha Monteith and Dr. Andrew Hershey discuss appropriate treatment strategies to prevent migraines in children and adolescents. Show citation:  Hershey AD, Szperka CL, Barbanti P, et al. Fremanezumab in Children and Adolescents with Episodic Migraine. N Engl J Med. 2026;394(3):243-252. doi:10.1056/NEJMoa2504546  Show transcript:  Dr. Tesha Monteith: This is Tesha Monteith with the Neurology Minute. I'm back with Andrew Hershey, professor of Pediatrics and Director of the Division of Neurology at Cincinnati Children's and the Children's Headache Center. This is part two of our discussion on his paper published in the New England Journal of Medicine, fremanezumab in Children and Adolescents with Episodic Migraine. Andrew, now that we have fremanezumab approved for prevention of episodic migraine in children and adolescents, and we have a number of other devices and treatments for patients that can be used as part of FDA-approved treatment or even off-label, can you discuss an appropriate treatment paradigm to prevent migraine? Dr. Andrew Hershey: I think the first and foremost part of the paradigm is to identify the disease, so recognition that headaches are a component of the disease migraine, so you have headaches attacks due to migraine is an essential part. Many of the children, adolescents and their families are unaware that that is even what they're having, and clarifying the etiology actually goes a long way. One of my former mentors, Dr. Prensky, always said that 50% of kids get better from just seeing a child neurologist, and I think it's that clarification of the diagnosis. Second to that, you need to provide a very adequate acute treatment as well as what's probably even more essential than anything else is healthy lifestyle habits. So regular eating, drinking, sleeping, and exercise. And then finally, if the headache is causing severe disability or frequent headaches or interfering with the child's school, home or social life, the prevention medications may need to be added. And this is where the fremanezumab, or if you prefer devices, devices can be used for both the acute and preventive treatment. Dr. Tesha Monteith: Well, thank you for the summary, and congratulations again on your paper. Dr. Andrew Hershey: Thank you. Dr. Tesha Monteith: Do check out the full podcast for more details about the paper and treatment of migraine in children and adolescents. This is Tesha Monteith. Thank you for listening to the Neurology Minute.

Hello Beautiful, I'm so grateful you're here with me.

You're eating healthy, exercising, managing stress. So why do you crave bread, pasta, and crackers like your life depends on it? And why does chicken breast sound about as appealing as chewing cardboard? In this episode, I reveal the hidden epidemic among women with chronic migraines that no one is talking about: low appetite. Not lack of hunger, but the kinds of foods your body finds appealing versus repulsive. Most women assume their food cravings are genetic or emotional. But I've found that in 9 out of 10 cases, it's neither. Your appetite is actually a direct expression of your digestive function. When your digestive tract struggles to break down food, your body changes what appeals to you to match what it can actually process. I break down what's happening in your digestive tract, why comfort foods feel soothing while nutrient-dense foods feel like a chore, and why forcing yourself to follow healthy eating handouts when your digestion can't handle it will likely trigger a migraine. This episode is for you if you struggle to eat enough food in a day, if you live on carbs and find protein unappealing, if eating healthier makes you feel worse, or if you're ready to restore your digestive function instead of forcing your body to comply. If you're having 8+ migraine days per month and you're ready to address the root cause, I can help.Schedule your free consultation here:https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map In health,Dr. Leslie Cisar

In part one of this two-part series, Dr. Tesha Monteith and Dr. Andrew Hershey summarize findings from the SPACE trial evaluating fremanezumab in adolescents and children with migraine. Show citation: Hershey AD, Szperka CL, Barbanti P, et al. Fremanezumab in Children and Adolescents with Episodic Migraine. N Engl J Med. 2026;394(3):243-252. doi:10.1056/NEJMoa2504546  Show transcript:  Dr. Tesha Monteith: Hi, this is Tesha Monteith with the Neurology Minute. I'm here with Andrew Hershey, Professor of Pediatrics and Director of the Division of Neurology at Cincinnati Children's and the Children's Headache Center. We're here talking about his new paper published in the New England Journal of Medicine, Fremanezumab in Children and Adolescents with Episodic Migraine. Andrew, thank you for being on our Neurology Minutes. Dr. Andrew Hershey: Thank you for inviting me. Dr. Tesha Monteith: Can you summarize the findings of the space trial investigating Fremanezumab for adolescents and children with migraine? Dr. Andrew Hershey: This is one of the four monoclonal antibodies against CGRP, or it's this receptor that had been proven effective for adults. And it's the first one, the formazepam, that's been able to report its effectiveness in children and adolescents with less than 15 headache days per month. This study looked at over 200 children adolescents that were in a double-blinded randomized placebo controlled study. And reached its primary, as well as its secondary endpoint of a reduction compared to placebo. And the number of attacks of migraine per month, as well as a greater than 50% reduction in the number of headache attacks per month, with minimal to no side effects, the most notable side effect being injection site erythema. Dr. Tesha Monteith: Great. Thank you so much for providing that update. Do check out the full podcast for more details about his paper and the treatment of migraine in children and adolescents. This is Tesha Monteith. Thank you for listening to the Neurology Minute.  

Send a textDr. Angela Stanton is a beloved returning guest on our show! Be sure to check out her first appearances on episode 70 and on episode 288 of Boundless Body Radio, both of which are some of our most downloaded and talked about episodes of all-time!Dr. Angela Stanton is a neuro-economist who evaluates changes in human behavior, including chronic pain, decision making, and hormonal variations in the brain. Her current research is focused on migraine cause, prevention and treatment without the use of medicines, and her discovery was helped by experimenting on herself.As a long-term sufferer of migraines herself, Dr. Stanton has dedicated her life to finding their root cause and developed the Stanton Migraine Protocol. She has written many books, including Fighting the Migraine Epidemic: Complete Guide: How to Treat and Prevent Migraines Without Medicines, a comprehensive body of work on migraine prevention and treatment without taking any medicines.Her book is a self-help guide with a full explanation about how to successfully abort and prevent all migraines. The book also provides a full explanation of the cause of migraines from a physiological, biological, and genetics perspective. She currently lives in Southern California.Find Dr. Stanton at-https://stantonmigraineprotocol.com/migraine-book.comNon-Profit- https://www.stantonmigraineprotocol.org/FB Group- Stanton Migraine ProtocolFB- Angela A. Stanton, Ph.D.IG- @drangelastantonTW- @MigraineBookFind Boundless Body at- myboundlessbody.com Book a session with us here!

In this episode of the Health Fix Podcast, Dr. Jannine Krause sits down with Dr. Jono Taves, a specialist in headache and migraine care, to break down why headaches are rarely "just in your head." Dr. Taves explains how neck mechanics, airway health, breathing patterns, and daily lifestyle choices play a critical role in headache frequency and severity. This conversation dives into often-overlooked root causes like tongue ties, mouth breathing, and lack of movement and why treating headaches requires a personalized, whole-body approach.

Craig sets up Pete Hoffman and the rest is brilliant! Plus, the Jets best asset going into next season is to dream!

What starts as a serious breakdown of Francisco Lindor's hand injury timeline quickly spirals into absolute chaos. Craig Carton and Chris McMonigle debate Mets injury recoveries, compare Lindor to Alvarez, and then everything goes off the rails — migraines, lights turned off in the studio, fake Todd Hundley fallout, and nonstop Carton Show comedy. Sports talk meets pure radio madness on WFAN.

Dr. Tesha Monteith talks with Dr. Andrew D. Hershey about the advancements in the treatment of pediatric migraines.  Read the related article in The New England Journal of Medicine.  Disclosures can be found at Neurology.org. 

Neurologist Dr. Vinit Banga explains stress, sleep, stroke symptoms, brain health, and the effects of pollution on the brain in this powerful podcast episode with Gaurav Arora.This episode covers:•Stress symptoms and how chronic stress damages the brain•Deep sleep and why sleep is essential for brain repair•Stroke warning signs (FAST symptoms) and why minutes matter•Brain fog, memory loss, cognitive decline, early dementia signs•Delhi pollution / AQI effects on brain ageing and intelligence•Migraine triggers, headaches, and dangerous neurological red flags•Doctor-patient trust, Practo ratings, healthcare commercialization in India00:00 Impact of Delhi's Pollution on Brain Health00:37 Stress and Its Effects on Health01:39 Air Quality and Brain Aging03:24 Blood-Brain Barrier and Pollution06:03 Memory Issues and Aging07:04 Understanding Memory Formation12:20 Sleep Disorders and Brain Health13:35 The Importance of Deep Sleep16:09 Stress: The Silent Disruptor46:38 Doctor-Patient Trust and Ethical Concerns55:14 Commercialization in Healthcare01:04:15 Concluding Thoughts and GratitudeDr. Vinit Banga is Director & Head of Neurology & Neurovascular Intervention at Fortis Escorts, and shares life-saving insights on preventing stroke, protecting brain function, and understanding modern neurological risk factors.Keywords: neurologist podcast, brain health India, stress and stroke, sleep and brain, stroke symptoms, stroke warning signs, Delhi pollution brain damage, brain fog, dementia signs, migraine, Fortis neurologist, Dr Vinit Banga, Gaurav Arora podcast.#Stress #Stroke #BrainHealth #Sleep #Neurology #Podcast #DrVinitBanga

You finally slow down. The emails stop. The alarm is off. The pressure lifts. And then, the migraine arrives.In this episode of Migraine Heroes Podcast, host Diane Ducarme, we explore the strange and frustrating paradox of week-end migraines: why the moment you rest, your body seems to revolt. What feels like cruel irony is actually a well-documented nervous-system response, and once you understand it, it becomes something you can work with rather than fear.This episode unpacks why migraine brains don't always respond well to abrupt shifts, even when those shifts are positive and how both Western science and Eastern medicine explain this phenomenon in surprisingly aligned ways.In this episode, you'll learn:Why “let-down” migraines happen and how sudden drops in stress hormones can destabilize a sensitive nervous systemHow the brain adapts to high pressure during the week, then struggles when that pressure suddenly disappearsThe Eastern perspective on why a sharp transition from doing to being can cause energy to surge upward instead of settlingA simple, gentle strategy to soften the transition from workweek to weekend so rest becomes restorative, not triggeringThis episode isn't about avoiding rest. It's about changing the way you arrive there. If your migraines tend to show up just when you think you're finally safe to relax, this conversation may help you rethink weekends not as a cliff, but as a bridge.

A new survey has found a high number of people reporting migraine symptoms, but many aren't receiving a formal diagnosis.

Send us a textIn this episode, Dr. Amy Gelfand, a child neurologist specializing in pediatric headaches, discusses the complexities and treatment of migraines in children. Gelfand explains the genetic nature of migraines and their commonality among kids, noting triggers like menstrual cycles and changes in sleep patterns. She elaborates on distinguishing features of migraines and provides insight into preventive and acute treatments, including NSAIDs, triptans, neuromodulation devices, and supplements. The discussion also covers the importance of a regular schedule, the benefits of cognitive behavioral therapy (CBT), and recent advancements in migraine-specific medications. Dr. Gelfand emphasizes the significant progress in migraine treatment and encourages families to consult specialists for personalized care.About Dr Gelfand:Dr. Amy Gelfand is a pediatric neurologist who specializes in diagnosing and treating children with a variety of headache disorders, as well as those with childhood periodic syndromes (such as abdominal migraine), which may be precursors to migraine headache later in life. Her research focuses on the epidemiology of pediatric migraine and childhood periodic syndromes.Gelfand received her medical degree from Harvard Medical School. She completed residencies in pediatrics and child neurology at UCSF.Gelfand has received a teaching award from the UCSF pediatric residency program and writing awards from the medical journal Neurology. She is a member of the American Academy of Neurology, Child Neurology Society and American Headache Society.Your Child is Normal is the trusted podcast for parents, pediatricians, and child health experts who want smart, nuanced conversations about raising healthy, resilient kids. Hosted by Dr. Jessica Hochman — a board-certified practicing pediatrician — the show combines evidence-based medicine, expert interviews, and real-world parenting advice to help listeners navigate everything from sleep struggles to mental health, nutrition, screen time, and more. Follow Dr Jessica Hochman:Instagram: @AskDrJessica and Tiktok @askdrjessicaYouTube channel: Ask Dr Jessica If you are interested in placing an ad on Your Child Is Normal click here or fill out our interest form.-For a plant-based, USDA Organic certified vitamin supplement, check out : Llama Naturals Vitamin and use discount code: DRJESSICA20-To test your child's microbiome and get recommendations, check out: Tiny Health using code: DRJESSICA The information presented in Ask Dr Jessica is for general educational purposes only. She does not diagnose medical conditi...

If you're looking for long-term migraine relief (not temporary fixes), this episode breaks down the three essentials you can't overlook.In this episode of The Headache Doctor Podcast, Dr. Taves explains Novera Headache Center's Three-Spoke Framework for true, root-cause migraine relief:The source of pain (often the neck, jaw, and shoulders)Why you got here (hidden barriers like airway issues, hypermobility, or past injuries)Your general health threshold (sleep, stress, gut health, hormones)You'll learn why triggers like food, weather, exertion, or hormones don't fully explain migraine pain—and why addressing only one piece of the puzzle often leads to short-term relief that doesn't last.Novera: Headache Center

I came across a viral video promising three "instant migraine relief" tricks. The usual ice water face dunks, cold plunges, and hyperventilation breathing... Of course I had to respond. In this episode, I break down why these trendy migraine hacks can actually make you feel worse. Ice water is terrible if you have Raynaud's syndrome (extremely common among migraine sufferers). Cold plunges add massive physical stress when your body is already struggling, and breathing exercises aren't realistic when the slightest movement makes your head explode. Here's the reality: when you're in a migraine, your resilience and vitality are already overwhelmed. Adding extreme stress like ice baths is like beating a horse that's already down. These "biohacking" tricks work for people who feel good and want to feel better, but they backfire for people whose bodies are already generating symptoms. Instead of wasting months on ice water experiments, I share a client story, a woman who went from twelve to fourteen-day migraine flares to one-day minimal flares in five weeks and flew to Hawaii without ruining her trip. If you're tired of throwing spaghetti at the wall and ready to address the root causes, let's talk. Schedule your free consultation below: https://www.drlesliecisar.com/apply Free Training: 5 Proven Steps to Being Migraine Free (Even if you think you've already tried everything.) https://www.drlesliecisar.com/5SHMN Connect with us: Website: https://www.drlesliecisar.com/ Free Facebook Group: Healing Migraines Naturally, with Leslie Cisar, ND Ready to try something radically different that actually works? Read more about my approach here: https://www.drlesliecisar.com/map

Dr. Tesha Monteith and Dr. Michael Eller discuss the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Show citation: Eller MT, Schwarzová K, Gufler L, et al. CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review. Neurology. 2025;105(2):e213852. doi:10.1212/WNL.0000000000213852  Show transcript:  Dr. Tesha Monteith: Hi, this is Tesha Monteith with the Neurology Minute. I've just been speaking with Michael Eller from the Department of Neurology Medical University of Innsbruck, Austria on the neurology podcast on his paper, CGRP Targeted Migraine Therapies in Patients with Vascular Risk Factors or Stroke: A Review. Hi, Michael. Dr. Michael Eller: Hello. Dr. Tesha Monteith: Why don't you summarize your general approach to use of CGRP targeted therapies in patients that might be at risk for vascular events when considering safety? Dr. Michael Eller: Yeah. About acute vascular events, we should stop CGLP targeted drugs immediately. When we come to post-stroke, we should reassess the necessity of these targeted treatments after recovery. We suggest a minimum of three months pause after ischemic stroke to allow early recovery and remodeling, and then restart only after individualized benefit risk review. In high-risk primary prevention, so no stroke yet, but elevated risk, if the patients are 65 years or older with established cardiovascular disease, we should prefer traditional preventives. And if CGLP targeted therapy is essential, we should consider Gepants cautiously due to their shorter half lives. We should avoid CGLP targeted treatments in small vessel disease, distal stenosis, Raynaud's phenomenon, and uncontrolled hypertension. For acute migraine treatment, we can consider gepants or ditans as alternatives to triptans and NSAIDs in relevant stroke risk or post-stroke patients, individualized to comorbidities. Dr. Tesha Monteith: Great. And we should say that the label updates include hypertension and Raynaud's phenomenon as potential vascular complications. Otherwise, these are more theoretical risks based on what we know about CGRP. Dr. Michael Eller: Yes, I totally agree because large studies did not show any elevated cardiovascular risk signals. And for post-marketing databases, we did not see any elevated cardiovascular risk so far. However, in pre-clinical settings, studies showed large infarct size in pretreated mice. Dr. Tesha Monteith: Great. Well, thank you again for doing this work. It was a phenomenal read and congratulations. Dr. Michael Eller: Thank you. Dr. Tesha Monteith: This is Tesha Monteith. Thank you for listening to the Neurology Minute.

Migraines are a debilitating neurological condition affecting millions—and no one who has experienced one takes them lightly. In the United Kingdom alone, an estimated 10 million adults suffer from migraines, costing millions of lost workdays each year. So when headlines recently declared that scientists have pinpointed a reason migraines are on the rise, it sounded like an important public-health breakthrough. But there was a familiar twist. According to the popular press, the culprit is—of course—climate change. Rising temperatures, turbulent weather patterns, and even anxiety about climate change itself are now being blamed for an alleged migraine “epidemic.” But does the evidence actually support these claims? In this episode of Created to Reign, David R. Legates takes a closer look at what the studies really say, what they don't say, and how correlation is being dressed up as causation. From daily and seasonal migraine patterns to the role of stress, diagnosis, and media framing, this episode asks a simple question: are migraines increasing because of climate change—or because climate change has become the go-to explanation for everything?https://www.dailymail.co.uk/health/article-15422347/Scientists-pinpoint-reason-people-getting-migraines.htmlhttps://www.nationalgeographic.com/health/article/migraines-climate-change-weather-heat-pressure https://pubmed.ncbi.nlm.nih.gov/9664747/https://link.springer.com/article/10.1186/s10194-021-01276-wVisit our podcast resource page: https://cornwallalliance.org/listen%20to%20our%20podcast%20created%20to%20reign/Our work is entirely supported by donations from people like you. If you benefit from our work and would like to partner with us, please visit www.cornwallalliance.org/donate.

Dr. Tesha Monteith talks with Dr. Michael Eller about the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.  Read the related article in Neurology®. Disclosures can be found at Neurology.org. 

Many people living with migraine know ice and heat can offer relief, but why do these simple tools help? In this episode of Spotlight on Migraine, host Molly O'Brien speaks with Alicia Duyvejonck, DNP, AGNP-C, AQH, about the science behind temperature therapy and shares best practices for safely using ice and heat to manage migraine pain.  Read the transcript at: https://www.migrainedisorders.org/podcast/s7ep9-ice-and-heat-for-migraine-how-temperature-therapy-works *The contents of this video are intended for general informational purposes only and do not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD does not recommend or endorse any treatment, products, or procedures mentioned. Reliance on any information provided by this content is solely at your own risk.

Dr. Hoffman continues his conversation with Dr. Elena Gross, an expert on migraines and brain metabolism. She is the founder and CEO of KetoSwiss and MigraKet, is a passionate neuroscientist, has a PhD in clinical research, and is a former chronic migraine sufferer.

Unraveling Migraines with Dr. Elena Gross, an expert on migraines and brain metabolism. She is the founder and CEO of KetoSwiss and MigraKet, is a passionate neuroscientist, has a PhD in clinical research, and is a former chronic migraine sufferer. Dr. Gross discusses her personal journey with chronic migraines and how it led her to develop innovative, natural approaches to migraine relief. She does a deep-dive into the nuances of brain energy, metabolism, oxidative stress, and the role of ketone bodies. Dr. Gross highlights her product line 'Brain Ritual' and how it can support brain health and tackle migraine symptoms. She also touches on the broader implications of these approaches for various neurodegenerative and psychiatric conditions. The discussion aims to offer practical solutions and a holistic understanding of brain health.Click here for $30 off your purchase of Brain Ritual.

Prodrome is one of those things I get asked about a lot. But not in the way that's quite so direct. Most people don't know that what they're asking me about is actually “prodrome.” The question usually comes in as something like, “I'm having [insert symptom]—why is that?” In this episode, we'll dig into: The 4 phases of a vestibular migraine What to know about the interictal phase Symptoms of prodrome you might be missing How to start tracking your prodrome phase How to treat the prodrome phase As mentioned, some people think they don't have a prodrome phase of their migraine when in reality… they're just missing it. Prodrome is pretty cool because you can get yourself out of the attack simply by recognizing your symptoms. (Yeah, pretty powerful!) We have so many more resources about building your toolkit and growing a bigger bucket waiting for you in Vestibular Group Fit (use code GROUNDED for 15% off your first subscription cycle). Related Episodes: How to Navigate the Stages of Migraine: https://thevertigodoctor.com/podcast/121-stages-of-vestibular-migraine-headache/ Links Mentioned: Vestibular Group Fit (code GROUNDED at checkout for 15% off!): https://thevertigodoctor.com/vestibular-group-fit Free Resources: ⁠The 4 Steps to Managing Vestibular Migraine: https://thevertigodoctor.myflodesk.com/cb5js0y78n ⁠The PPPD Management Masterclass⁠: https://thevertigodoctor.myflodesk.com/new-pppd ⁠What your Partner Should Know About Living with Dizziness⁠: https://thevertigodoctor.myflodesk.com/partnership ⁠The FREE Mini VGFit Workout⁠: https://thevertigodoctor.myflodesk.com/minifit ⁠The FREE POTS – safe Workouts⁠: https://thevertigodoctor.myflodesk.com/pots Connect with Dr. Madison (@TheVertigoDoctor): https://instagram.com/thevertigodoctor Work with Dr. Madison: For 1:1 Vestibular Rehabilitation Therapy, email madison@thevertigodoctor.com Otherwise, I'll see ya in Vestibular Group Fit! Connect with Dr. Jenna (@dizzy.rehab.therapist): https://www.instagram.com/dizzy.rehab.therapist/ Learn about the Oak Method: http://thevertigodoctor.com/why-vestibular-group-fit Love what you heard? Reviews really help us out! Please consider leaving one for us.  This podcast is for informational purposes only and may not be the best fit for you and your personal situation. It shall not be construed as medical advice. The information and education provided here is not intended or implied to supplement or replace professional medical treatment, advice, and/or diagnosis. Always check with your own physician or medical professional before trying or implementing any information read here. Amazon Affiliate Disclaimer: As an Amazon Associate, I earn from qualifying purchases with no extra cost to you. Dr. Madison Oak, PT is a dedicated vestibular physical therapist committed to enhancing the quality of life for individuals grappling with chronic vestibular conditions. She is the proprietor of Oak Physical Therapy & Wellness, a reputable telehealth vestibular rehabilitation therapy practice catering to clients across six states. Additionally, Dr. Oak is the visionary behind Vestibular Group Fit, an esteemed international group program. With over 500 members, her program has successfully empowered individuals with vestibular disorders to reclaim control over their lives. ————————————— what is prodrome, migraine prodrome, prodrome phase, stages of migraine headache, vestibular migraine, VM, how to treat the phases of a migraine, vestibular migraine symptoms, prodrome examples, interictal, chronic migraine, migraine toolkit

How treatable are your headaches or migraines — and what determines how quickly you can see relief?In this episode, Dr. Jono Taves breaks down why all headaches are treatable, but not all follow the same recovery timeline. Drawing from over a thousand real patient cases, he explains how symptom frequency, pain patterns, and overall health help predict how the body responds to care.Dr. Taves walks through the key differences between constant daily headaches and intermittent migraines, explains the role of central sensitization, and shows why headaches that start in the neck often respond more quickly when the mechanical source is addressed. He also clarifies why many headache diagnoses are based on symptoms rather than root cause — and how that affects long-term outcomes.If you've ever wondered whether your headaches are “too chronic,” “too complex,” or “too ingrained” to improve, this episode offers clarity, realistic expectations, and hope grounded in clinical experience.Novera: Headache Center

Dr. Tesha Monteith highlights the American Headache Society's position statement, which advocates for migraine screening in girls and women.  Show citation: Schwedt TJ, Starling AJ, Ailani J, et al. Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society. Headache. Published online December 10, 2025. doi:10.1111/head.70023 Show transcript:  Dr. Tesha Monteith: Hi, this is Tesha Monteith with the Neurology Minute. Welcome back to our Women's Health and Headache Medicine series. Did you know the American Headache Society recently published a position statement to encourage screening for migraine in girls and women? The position statement was based on review of the literature to establish if migraine met standards for screening in subpopulations and to assess appropriate screening tools. The team achieved consensus, agreeing that migraine, due to its prevalence, morbidity, high cost, availability of screening methods and treatments, does meet criteria to justify screening for girls and women. The panel suggested that migraine should be screened annually as part of women's preventative care with tools like ID-Migraine. ID-Migraine is a self-administered three-question survey that has been validated in primary care settings. Patients answer yes or no to having the following with headache over the past three months. Patients are asked if headaches limited your ability to work, study, or do what they need to do on at least one day. You felt nauseated or sick to your stomach. Light bothered you a lot more than when you don't have headaches. Answering at least two of the three is positive for migraine. The panel acknowledged certain barriers, but they ultimately emphasize the overwhelming benefits of screening for migraine in women and children. Although the focus is for females, they recognize benefits in boys and men as well. Check out this position statement. It's a great read. This is Tesha Monteith. Thank you for listening to the Neurology Minute.